ICBP Resources
Contact the ICBP team
If you have any views or comments about the partnership, we would like to hear from you.
The ICBP develops a range of tools, briefings and other resources. When these may be useful to the wider policy and research communities, we will make them available on this page.
These resources can be used in presentations, reports or other communications in line with the Cancer Research UK citation guide. Please contact the ICBP Programme Management team (icbp@cancer.org.uk) for more information about any of the resources on this page.
The CanStaging+ tool is available at http://canstaging.org providing online (and offline, for limited online-service settings) access to up-to-date rules and standards in a free, intuitive, and open-source software to support better recording and increased completeness and quality of population level staging data. The tool automatically calculations T,M,N stage data based on raw information entered, and will provide a range of stage groups when data entered is limited. In addition to stage group, essential TMN, FIGO, and Dukes calculations can also be provided. Images and flowcharts are available to assist with manual stage classification as well as education.
- Specific time intervals and details of a patient’s route to diagnosis and treatment.
- The number of times a patient saw a health care professional before diagnosis.
- The nature of any referrals and diagnostic tests carried out.
- Associations between these factors and a range of patient outcomes (including survival and stage at diagnosis).
Reports
Our showcase reports provide an update on progress within the partnership, including findings, the impacts of our research and ongoing studies. These reports provide an overview of the partnership at certain points in time.
ICBP: Evidence for policy and practice (2016)
ICBP: Showcasing our findings and impacts (2014)
ICBP in other publications and communications
ICBP work often feeds in to the work of other organisations, including in publications, blogs and other forms of communications. Here we have provided a selection:
Building an Evidence-Based Approach to Improving Cancer Outcomes (EFPIA View 2017)
How to improve cancer survival: Exploring England’s relatively poor rates (The King’s Fund 2011)
1 and 3 year survival by stage - pancreatic - jurisdictions
3-year survival by stage and ages - pancreatic - countries
1 and 3 - year survival by stage - pancreatic - countries
3-year survival by distant stage - ovarian cancer - older patients - Canada
3-year survival by distant stage - ovarian cancer - older patients - UK
3-year survival by stage - NSCLC - Canadian and UK jurisdictions
3-year survival by stage - NSCLC - female
3-year survival by stage - NSCLC - male
3-year survival by stage - NSCLC & SCLC - all countries
3-year survival by stage - ovarian cancer - all countries
3-year survival by stage - ovarian cancer - Canada
3-year survival by stage - ovarian cancer - older patients - all countries
3-year survival by stage - ovarian cancer - UK
3-year survival by stage - SCLC - Canadian and UK jurisdictions
3-year survival by stage - SCLC - female
3-year survival by stage - SCLC - male
5-year survival by stage - colon cancer
5-year survival by stage - rectal cancer
Lung overview - sex differences
3-year oesophageal and gastric survival UK only
3-year oesophageal and gastric survival
1 year survival all jurisdictions - ovarian cancer
1 year survival all jurisdictions - colon cancer
1 year survival all jurisdictions - lung cancer
1 year survival all jurisdictions - oesophageal cancer
1 year survival all jurisdictions - pancreatic cancer
1 year survival all jurisdictions - rectal cancer
1 year survival all jurisdictions - stomach cancer
5 year survival all jurisdictions - colon cancer
5 year survival all jurisdictions - lung cancer
5 year survival all jurisdictions - oesophageal cancer
5 year survival all jurisdictions - ovarian cancer
5 year survival all jurisdictions - pancreatic cancer
5 year survival all jurisdictions - rectal cancer
5 year survival all jurisdictions - stomach cancer
Incidence, mortality and survival - lung cancer
Incidence, mortality and survival - colon cancer
Incidence, mortality and survival - oesophageal cancer
Incidence, mortality and survival - ovarian cancer
Incidence, mortality and survival - pancreatic cancer
1-year - Over 75 Comparisons - all cancers
3-year survival - Lung - 75 years old
3-year survival - Oesophageal - 75 years old
3-year survival - Ovarian- 75 years old
3-year survival - Stomach - 75 years old
3-year survival- Pancreatic - 75 years old
5-year - Over 75 Comparisons - Colon
5-year - Over 75 Comparisons - Lung
5-year - Over 75 Comparison - Oesophageal
5-year - Over 75 Comparisons - Ovarian
5-year - Over 75 Comparisons - Pancreatic
5-year - Over 75 Comparisons - Rectal
5-year - Over 75 Comparisons - Stomach
Infographics for the usage of and time-to-treatment for radiotherapy and chemotherapy for all cancer sites.
See also
Join us on X (previously known as Twitter)
Join the conversation and follow @CRUKHCPs for news, updates and opinion. |
|